These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
150 related items for PubMed ID: 11852699
1. Comparative evaluation of co-processed lactose and microcrystalline cellulose with their physical mixtures in the formulation of folic acid tablets. Michoel A, Rombaut P, Verhoye A. Pharm Dev Technol; 2002 Jan; 7(1):79-87. PubMed ID: 11852699 [Abstract] [Full Text] [Related]
2. A study of a new co-processed dry binder based on spray-dried lactose and microcrystalline cellulose. Mužíková J, Sináglová P. Ceska Slov Farm; 2013 Jun; 62(3):127-31. PubMed ID: 23961814 [Abstract] [Full Text] [Related]
3. Cellactose a co-processed excipient: a comparison study. Arida AI, Al-Tabakha MM. Pharm Dev Technol; 2008 Jun; 13(2):165-75. PubMed ID: 18379907 [Abstract] [Full Text] [Related]
4. Comparison of properties of tablets and energy profile of compaction of two spray-dried lactoses. Muzíková J, Sináglová P. Acta Pol Pharm; 2013 Jun; 70(1):129-35. PubMed ID: 23610968 [Abstract] [Full Text] [Related]
5. A study of micronized poloxamers as lubricants in direct compression of tablets. Muzíková J, Vyhlídalová B, Pekárek T. Acta Pol Pharm; 2013 Jun; 70(6):1087-96. PubMed ID: 24383332 [Abstract] [Full Text] [Related]
6. Influence of formulation composition and processing on the content uniformity of low-dose tablets manufactured at kilogram scale. Morris DG, Truitt BF, Kong A, Leyva N, Luner PE. Pharm Dev Technol; 2009 Jun; 14(5):451-60. PubMed ID: 19552558 [Abstract] [Full Text] [Related]
7. Development of immediate release Rupatadine fumarate 10 mg tablets: A Quality by Design (QbD) approach. Castillo Henríquez L, Vargas Zúñiga R, Carazo Berrocal G, Madrigal Redondo G, Calvo Guzmán B, Baltodano Viales E. Drug Dev Ind Pharm; 2019 Oct; 45(10):1674-1681. PubMed ID: 31378098 [Abstract] [Full Text] [Related]
8. Comparative evaluation of the use of dry binders in a physical mixture or as a coprocessed dry binder in matrix tablets with extended drug release. Mužíková J, Komersová A, Lochař V, Vildová L, Vošoustová B, Bartoš M. Acta Pharm; 2018 Sep 01; 68(3):295-311. PubMed ID: 31259696 [Abstract] [Full Text] [Related]
10. A study of the properties of tablets from coprocessed dry binders composed of alpha-lactose monohydrate and different types of cellulose. Muzíková J, Zvolánková J. Ceska Slov Farm; 2007 Dec 01; 56(6):269-75. PubMed ID: 18257417 [Abstract] [Full Text] [Related]
11. A microcrystalline cellulose based drug-composite formulation strategy for developing low dose drug tablets. Sun WJ, Sun CC. Int J Pharm; 2020 Jul 30; 585():119517. PubMed ID: 32526333 [Abstract] [Full Text] [Related]
16. Application of crustacean chitin as a co-diluent in direct compression of tablets. Mir VG, Heinämäki J, Antikainen O, Sandler N, Revoredo OB, Colarte AI, Nieto OM, Yliruusi J. AAPS PharmSciTech; 2010 Mar 30; 11(1):409-15. PubMed ID: 20238188 [Abstract] [Full Text] [Related]
17. An experimental investigation of the effect of the amount of lubricant on tablet properties. Perrault M, Bertrand F, Chaouki J. Drug Dev Ind Pharm; 2011 Feb 30; 37(2):234-42. PubMed ID: 20704461 [Abstract] [Full Text] [Related]
20. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets. Lin SY, Lin KH, Li MJ. J Pharm Sci; 2002 Sep 30; 91(9):2040-6. PubMed ID: 12210050 [Abstract] [Full Text] [Related] Page: [Next] [New Search]